More women need to be diagnosed in the early stage of ovarian cancer when treatment has a much higher success rate. With early detection difficult it is important that all women are aware of the symptoms of ovarian cancer.
Our purpose is to support locals fighting gynaecological cancers by raising funds for research and clinical trials, as well as raising awareness to assist with early diagnosis.
Our goal is to eradicate gynaecological cancers fully through assisting with research and clinical trials.
Overall survival: The overall five-year relative survival rate for ovarian cancer in Australia is around 49% (for those diagnosed during 2015–2019) – CANCERAUSTRALIA.GOV.AU
In comparison, ovarian cancer has one of the lowest survival rates of any female cancer in Australia – DAFFODILCENTRE.ORG
Late-stage prognosis: Outcomes are much better when ovarian cancer is caught early. If diagnosed at an advanced stage, the prognosis is poor – the five-year survival rate is below 30% for women with late-stage ovarian cancer – WWW1.RACGP.ORG.AU, whereas early-stage (confined to the ovary) cases have a significantly higher survival rate (often 80–90% five-year survival in stage I, according to clinical data).
New cases: Approximately 1,786 new cases of ovarian cancer are projected to be diagnosed in Australia in 2023, accounting for about 2.4% of all new cancers in Australian females. This translates to an age-standardised incidence rate of around 13 cases per 100,000 women
CANCERAUSTRALIA.GOV.AU
Lifetime risk: An Australian woman has about a 1 in 87 (1.2%) chance of being diagnosed with ovarian cancer by the age of 85.
CANCERAUSTRALIA.GOV.AU
Prevalence (survivors): As of the end of 2018, roughly 5,173 women in Australia were living with ovarian cancer who had been diagnosed in the previous five years. (Over 13,600 women diagnosed with ovarian cancer since 1982 were alive in 2018, reflecting the long-term survivor population
CANCERAUSTRALIA.GOV.AU